Open an account

VanEck Healthcare TruSector ETF

TRUH · ETF

$31.28−$0.3496 (−1.11%)TodayMarket closed ·
Prev close $31.63

About TRUH

TRUH was created on 2026-04-01 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 0.57m in AUM and 61 holdings. TRUH is actively managed, seeking long-term capital appreciation through exposure to US companies in the healthcare sector. Stock selection uses a discretionary investment process.

Issuer
VanEck
Expense ratio
0.1%
Assets under management
$580.98K
Inception
Apr 1, 2026
Asset class
Equity
Website
vaneck.com

TRUH key statistics

Price-earnings ratio
0.00
Average volume
605
Volume
938
Open price
$31.32
High today
$31.41
Low today
$31.24
52 Week high
$31.63
52 Week low
$24.78

VanEck Healthcare TruSector ETF (TRUH) at a glance

VanEck Healthcare TruSector ETF (TRUH) last traded at $31.28, with a price-to-earnings ratio of 0.00.

Today the fund has traded between $31.24 and $31.41. The current price is 0.1% above the day's low and 0.4% below its high.

Volume so far is 938 shares, above the average of 605 shares a day.

Over the past year VanEck Healthcare TruSector ETF has ranged from $24.78 to $31.63, and now sits 95% of the way up that range.

TRUH news

  • Chandrima Sanyal

    VanEck's New ETFs Aim To Fix A Common Sector Investing Problem

  • Press releaseBusiness Wire

    VanEck Completes TruSector Suite Coverage of GICS Sectors with Launch of Four ETFs

  • Vandana Singh

    AbbVie Says Nine-Year Data Reinforces Venetoclax Benefit In Leukemia Patients

  • Press releaseBusiness Wire

    VanEck Adds Consumer Staples (TRUO) and Industrials (TRUI) to TruSector ETF Suite

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.